Clinical Trial

A Real-World Study of Precision Treatment for Advanced Cholangiocarcinoma Based on Molecular Subtyping

Name: A Real-World Study of Precision Treatment for Advanced Cholangiocarcinoma Based on Molecular Subtyping — clinical trial record (NCT07164703)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This is a multi-center, real-world study aiming to evaluate the efficacy and safety of precision treatment for advanced cholangiocarcinoma (CCA) with different molecular subtypes.

Trial Details

NCT Number	NCT07164703
Lead Sponsor	Mao-Lin Yan
Conditions	Advanced Cholangiocarcinoma (Part 1)
Enrollment	55 participants
Start Date	2025-10-01
Primary Completion	2029-10-01 (estimated)
Study Completion	2029-10-31 (estimated)
Updated on ClinicalTrials.gov	2025-09-10